Literature DB >> 8556252

Dermabrasion for prophylaxis and treatment of actinic keratoses.

W P Coleman1, J M Yarborough, S H Mandy.   

Abstract

BACKGROUND: After dermabrasion, patients with actinic keratoses remain free of new lesions for many years. This clinical effect has been alluded to for 40 years in the dermatologic literature. However, there has been no consensus on how long this clinical benefit actually lasts.
OBJECTIVE: To ascertain the longevity of the beneficial effect of dermabrasion, clinical records of patients who underwent this procedure for treatment of actinic keratosis were reviewed.
METHOD: Retrospective review.
RESULTS: A total of 23 such patients with at least 2 years good clinical follow-up were identified. Their ages ranged from 33 to 76 years. One year after dermabrasion, 96% remained free of new actinic keratoses. The benefits of dermabrasion gradually diminished with 83% clear at 2 years, 79% at 3 years, 64% at 4 years, and 54% at 5 years. The average time after dermabrasion before the appearance of one actinic keratoses was 4 years (median, 4.5 years). Dermabrasion, however did not prevent the appearance of basal cell carcinomas in the perinasal area.
CONCLUSION: Dermabrasion provides long-term effective prophylaxis against actinic keratoses and presumably squamous cell carcinomas. The benefits last for an average of 4 years before even one new actinic keratosis reappears. Cryosurgery, 5-Fluorouracil, and chemical peels result in much shorter prophylaxis. Dermabrasion is the most effective modality for prevention of new actinic keratoses.

Entities:  

Mesh:

Year:  1996        PMID: 8556252     DOI: 10.1111/j.1524-4725.1996.tb00565.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  10 in total

1.  Actinic keratoses: a comprehensive update.

Authors:  Sherrif F Ibrahim; Marc D Brown
Journal:  J Clin Aesthet Dermatol       Date:  2009-07

Review 2.  Actinic keratoses. Differential diagnosis and treatment.

Authors:  J W Barnaby; A R Styles; C J Cockerell
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

Review 3.  Fibroblast senescence and squamous cell carcinoma: how wounding therapies could be protective.

Authors:  Jeffrey B Travers; Dan F Spandau; Davina A Lewis; Christiane Machado; Melanie Kingsley; Nico Mousdicas; Ally-Khan Somani
Journal:  Dermatol Surg       Date:  2013-02-25       Impact factor: 3.398

4.  How Wounding via Lasers Has Potential Photocarcinogenic Preventative Effects via Dermal Remodeling.

Authors:  Aleksandar Krbanjevic; Jeffrey B Travers; Dan F Spandau
Journal:  Curr Dermatol Rep       Date:  2016-07-07

5.  Single Ablative Fractional Resurfacing Laser Treatment For Forearm Actinic Keratoses: 6-Month Follow-Up Data From An Intrapatient Comparison Between Treated and Untreated Sites.

Authors:  Roy Chen; Jeffrey J Wargo; Amy Williams; Elizabeth Cates; Dan F Spandau; Christina Knisely; Jeffrey B Travers
Journal:  Lasers Surg Med       Date:  2019-11-17       Impact factor: 4.025

6.  Skull base surgery for the management of deeply invasive scalp cancer.

Authors:  Paul James Donald; James Boggan; D Gregory Farwell; Danny J Enepekides
Journal:  Skull Base       Date:  2011-11

7.  In-office Painless Aminolevulinic Acid Photodynamic Therapy: A Proof of Concept Study and Clinical Experience in More Than 100 Patients.

Authors:  George M Martin
Journal:  J Clin Aesthet Dermatol       Date:  2016-02

8.  Reversing the aging stromal phenotype prevents carcinoma initiation.

Authors:  Davina A Lewis; Jeffrey B Travers; Christiane Machado; Ally-Khan Somani; Dan F Spandau
Journal:  Aging (Albany NY)       Date:  2011-04       Impact factor: 5.682

9.  Fractionated laser resurfacing corrects the inappropriate UVB response in geriatric skin.

Authors:  Dan F Spandau; Davina A Lewis; Ally-Khan Somani; Jeffrey B Travers
Journal:  J Invest Dermatol       Date:  2012-03-01       Impact factor: 8.551

10.  A randomized, double-blind, placebo-controlled clinical trial evaluating Dermytol(®) cream for the treatment of actinic keratoses.

Authors:  Malkanthi Evans; Douglas Kalman; Patricia Alvarez; Maryse Paquet; Najla Guthrie
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-08-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.